Back to Trades
Hannah Brendan
InsiderCIK 0001929422
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Hannah Brendan has filed 2 SEC reports (2025–2026), all concentrated in Quince Therapeutics, Inc. (QNCX), totaling $1.2M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Jan 23 | QNCX Quince Therapeutics, Inc. | Hannah Brendan | Insider | Award | $1.1M |
| Dec 8 | QNCX Quince Therapeutics, Inc. | Hannah Brendan | Insider | Exercise | $50.0K |
2 filings